A Phase I Study of the Wee 1 Kinase (Wee 1) Inhibitor AZD1775 (MK-1775) in Combination With Cisplatin and Radiation in Cervical Cancer (10041848, 10008224, 10008328)

Trial Profile

A Phase I Study of the Wee 1 Kinase (Wee 1) Inhibitor AZD1775 (MK-1775) in Combination With Cisplatin and Radiation in Cervical Cancer (10041848, 10008224, 10008328)

Suspended
Phase of Trial: Phase I

Latest Information Update: 13 Jul 2017

At a glance

  • Drugs AZD-1775 (Primary) ; Cisplatin
  • Indications Cervical cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 30 Apr 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Jun 2021.
    • 30 Apr 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Jun 2021.
    • 08 Dec 2016 Planned primary completion date changed from 1 Aug 2016 to 1 Mar 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top